| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |